Favorite  |  Set Home
Products > Others > > AN2728
Product name : AN2728
Item : CR1775
Price : 200mg, $845; 500mg, $1485
contact : Send inquiry to: info@acesobio.com
Additional Information :  We offer significant discount for bulky quantity order,Please ask price and availability of other quantities
CAS : 906673-24-3
 Enlarge Image                   Back
             [Next Product]→

 Chemical Information
M.Wt 251.05 Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Formula C14H10BNO3
CAS No 906673-24-3


Biological Activity of AN-2728


AN-2728 is a topically administered, boron-containing, anti-inflammatory compound that inhibits PDE4 activity and thereby suppresses the release of TNFalpha, IL-12, IL-23 and other cytokines.
IC50 value:
Target: PDE4
AN-2728 appears to have good therapeutic potential, although further and larger trials are required to assess the long-term safety and characterize the broad utility of this drug. AN-2728 shows potent activity both in vitro and in vivo. AN-2728 is now in clinical development for the topical treatment of psoriasis and being pursued for the topical treatment of atopic dermatitis.


Clinical Information of AN-2728


[1]. Freund YR, Akama T, Alley MR, et al. Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center. FEBS Lett. 2012 Sep 21;586(19):3410-4.
[2]. Tomotaka Mabuchi, Timothy W. Chang, Suzanne Quinter, et al. Chemokine receptors in the pathogenesis and therapy of psoriasis. Journal of Dermatological Science. 2012, 65(1) : 4-11
[3]. Y. Valdman-Grinshpoun, D. Ben-Amitai, A. Zvulunov. Barrier-Restoring Therapies in Atopic Dermatitis: Current Approaches and Future Perspectives. Dermatology Research and Practice Volume.2012, Article ID 923134, 6 pages
[4]. Nazarian R, Weinberg JM. AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis. Curr Opin Investig Drugs. 2009 Nov;10(11):1236-42.
[5]. Akama T, Baker SJ, Zhang YK, et al. Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2129-32.

Related Products :
Pneumocandin B0 (L 688786)
Pneumocandin B0 (L 688786)
Price: 5mg, $275, 10mg, $475, 50mg, $1285, 100mg, $1995
Merck SIP Agonist
Merck SIP Agonist
Price: 10mg, $125; 50mg, $495; 100mg, $995; 200mg, $1695
9-Aminominocycline hydrochloride
9-Aminominocycline hydrochloride
Price: 1g, $145; 5g, $550
CID 1067700
CID 1067700
Price: 10mg, $325; 50mg, $895; 100mg, $1695; 200mg,$2475
Price: 10mg, $125; 50mg, $395; 100mg, $595; 200mg, $995
NSC 23766
NSC 23766
Price: 10mg, $125; 50mg, $495; 100mg, $695; 200mg, $1095
Ramelteon (TAK 375, Rozerem)
Ramelteon (TAK 375, Rozerem)
Price: 10mg, $325; 50mg,$1175; 100mg, $1695; 200mg,$2475
CCG 50014
CCG 50014
Price: 10mg, $125; 50mg, $495; 100mg, $795; 200mg, $1095